Copyright Reports & Markets. All rights reserved.

Global EGFR Mutation Test Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of EGFR Mutation Test
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of EGFR Mutation Test by Type
    • 1.3.1 Overview: Global EGFR Mutation Test Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global EGFR Mutation Test Consumption Value Market Share by Type in 2023
    • 1.3.3 DNA Sequencing
    • 1.3.4 Kits
  • 1.4 Global EGFR Mutation Test Market by Application
    • 1.4.1 Overview: Global EGFR Mutation Test Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Cancer Hospitals
    • 1.4.3 Clinical Research Institutes
  • 1.5 Global EGFR Mutation Test Market Size & Forecast
  • 1.6 Global EGFR Mutation Test Market Size and Forecast by Region
    • 1.6.1 Global EGFR Mutation Test Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global EGFR Mutation Test Market Size by Region, (2019-2030)
    • 1.6.3 North America EGFR Mutation Test Market Size and Prospect (2019-2030)
    • 1.6.4 Europe EGFR Mutation Test Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific EGFR Mutation Test Market Size and Prospect (2019-2030)
    • 1.6.6 South America EGFR Mutation Test Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa EGFR Mutation Test Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott EGFR Mutation Test Product and Solutions
    • 2.1.4 Abbott EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Abbott Recent Developments and Future Plans
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck EGFR Mutation Test Product and Solutions
    • 2.2.4 Merck EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Merck Recent Developments and Future Plans
  • 2.3 Thermo Fisher Scientific
    • 2.3.1 Thermo Fisher Scientific Details
    • 2.3.2 Thermo Fisher Scientific Major Business
    • 2.3.3 Thermo Fisher Scientific EGFR Mutation Test Product and Solutions
    • 2.3.4 Thermo Fisher Scientific EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.4 Illumina
    • 2.4.1 Illumina Details
    • 2.4.2 Illumina Major Business
    • 2.4.3 Illumina EGFR Mutation Test Product and Solutions
    • 2.4.4 Illumina EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Illumina Recent Developments and Future Plans
  • 2.5 BioMerieux
    • 2.5.1 BioMerieux Details
    • 2.5.2 BioMerieux Major Business
    • 2.5.3 BioMerieux EGFR Mutation Test Product and Solutions
    • 2.5.4 BioMerieux EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 BioMerieux Recent Developments and Future Plans
  • 2.6 QIAGEN
    • 2.6.1 QIAGEN Details
    • 2.6.2 QIAGEN Major Business
    • 2.6.3 QIAGEN EGFR Mutation Test Product and Solutions
    • 2.6.4 QIAGEN EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 QIAGEN Recent Developments and Future Plans
  • 2.7 Agilent Technologies
    • 2.7.1 Agilent Technologies Details
    • 2.7.2 Agilent Technologies Major Business
    • 2.7.3 Agilent Technologies EGFR Mutation Test Product and Solutions
    • 2.7.4 Agilent Technologies EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Agilent Technologies Recent Developments and Future Plans
  • 2.8 Hologic
    • 2.8.1 Hologic Details
    • 2.8.2 Hologic Major Business
    • 2.8.3 Hologic EGFR Mutation Test Product and Solutions
    • 2.8.4 Hologic EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Hologic Recent Developments and Future Plans
  • 2.9 Novartis
    • 2.9.1 Novartis Details
    • 2.9.2 Novartis Major Business
    • 2.9.3 Novartis EGFR Mutation Test Product and Solutions
    • 2.9.4 Novartis EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Novartis Recent Developments and Future Plans
  • 2.10 Roche
    • 2.10.1 Roche Details
    • 2.10.2 Roche Major Business
    • 2.10.3 Roche EGFR Mutation Test Product and Solutions
    • 2.10.4 Roche EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Roche Recent Developments and Future Plans
  • 2.11 Genomic Health
    • 2.11.1 Genomic Health Details
    • 2.11.2 Genomic Health Major Business
    • 2.11.3 Genomic Health EGFR Mutation Test Product and Solutions
    • 2.11.4 Genomic Health EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Genomic Health Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global EGFR Mutation Test Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of EGFR Mutation Test by Company Revenue
    • 3.2.2 Top 3 EGFR Mutation Test Players Market Share in 2023
    • 3.2.3 Top 6 EGFR Mutation Test Players Market Share in 2023
  • 3.3 EGFR Mutation Test Market: Overall Company Footprint Analysis
    • 3.3.1 EGFR Mutation Test Market: Region Footprint
    • 3.3.2 EGFR Mutation Test Market: Company Product Type Footprint
    • 3.3.3 EGFR Mutation Test Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global EGFR Mutation Test Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global EGFR Mutation Test Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global EGFR Mutation Test Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global EGFR Mutation Test Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America EGFR Mutation Test Consumption Value by Type (2019-2030)
  • 6.2 North America EGFR Mutation Test Consumption Value by Application (2019-2030)
  • 6.3 North America EGFR Mutation Test Market Size by Country
    • 6.3.1 North America EGFR Mutation Test Consumption Value by Country (2019-2030)
    • 6.3.2 United States EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 6.3.3 Canada EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico EGFR Mutation Test Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe EGFR Mutation Test Consumption Value by Type (2019-2030)
  • 7.2 Europe EGFR Mutation Test Consumption Value by Application (2019-2030)
  • 7.3 Europe EGFR Mutation Test Market Size by Country
    • 7.3.1 Europe EGFR Mutation Test Consumption Value by Country (2019-2030)
    • 7.3.2 Germany EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 7.3.3 France EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 7.3.5 Russia EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 7.3.6 Italy EGFR Mutation Test Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific EGFR Mutation Test Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific EGFR Mutation Test Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific EGFR Mutation Test Market Size by Region
    • 8.3.1 Asia-Pacific EGFR Mutation Test Consumption Value by Region (2019-2030)
    • 8.3.2 China EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 8.3.3 Japan EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 8.3.5 India EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 8.3.7 Australia EGFR Mutation Test Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America EGFR Mutation Test Consumption Value by Type (2019-2030)
  • 9.2 South America EGFR Mutation Test Consumption Value by Application (2019-2030)
  • 9.3 South America EGFR Mutation Test Market Size by Country
    • 9.3.1 South America EGFR Mutation Test Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina EGFR Mutation Test Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa EGFR Mutation Test Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa EGFR Mutation Test Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa EGFR Mutation Test Market Size by Country
    • 10.3.1 Middle East & Africa EGFR Mutation Test Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia EGFR Mutation Test Market Size and Forecast (2019-2030)
    • 10.3.4 UAE EGFR Mutation Test Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 EGFR Mutation Test Market Drivers
  • 11.2 EGFR Mutation Test Market Restraints
  • 11.3 EGFR Mutation Test Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 EGFR Mutation Test Industry Chain
  • 12.2 EGFR Mutation Test Upstream Analysis
  • 12.3 EGFR Mutation Test Midstream Analysis
  • 12.4 EGFR Mutation Test Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global EGFR Mutation Test market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.
    Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.
    The Global Info Research report includes an overview of the development of the EGFR Mutation Test industry chain, the market status of Cancer Hospitals (DNA Sequencing, Kits), Clinical Research Institutes (DNA Sequencing, Kits), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of EGFR Mutation Test.
    Regionally, the report analyzes the EGFR Mutation Test markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global EGFR Mutation Test market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the EGFR Mutation Test market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the EGFR Mutation Test industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., DNA Sequencing, Kits).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the EGFR Mutation Test market.
    Regional Analysis: The report involves examining the EGFR Mutation Test market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the EGFR Mutation Test market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to EGFR Mutation Test:
    Company Analysis: Report covers individual EGFR Mutation Test players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards EGFR Mutation Test This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer Hospitals, Clinical Research Institutes).
    Technology Analysis: Report covers specific technologies relevant to EGFR Mutation Test. It assesses the current state, advancements, and potential future developments in EGFR Mutation Test areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the EGFR Mutation Test market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    EGFR Mutation Test market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    DNA Sequencing
    Kits
    Market segment by Application
    Cancer Hospitals
    Clinical Research Institutes
    Market segment by players, this report covers
    Abbott
    Merck
    Thermo Fisher Scientific
    Illumina
    BioMerieux
    QIAGEN
    Agilent Technologies
    Hologic
    Novartis
    Roche
    Genomic Health
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe EGFR Mutation Test product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of EGFR Mutation Test, with revenue, gross margin and global market share of EGFR Mutation Test from 2019 to 2024.
    Chapter 3, the EGFR Mutation Test competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and EGFR Mutation Test market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of EGFR Mutation Test.
    Chapter 13, to describe EGFR Mutation Test research findings and conclusion.

    Buy now